BIOLIFE SOLUTIONS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($6.9m)
($2.5m) +63.42%
$3.3m +229.86%
($1.7m) -150.73%
$2.7m +260.95%
($7.6m) -386.28%
($139.8m) -1731.11%
($66.4m) +52.49%
($20.2m) +69.61%
($4.6m) +77.23%
Net Income (Loss) Available to Common Stockholders, Basic ($2.7m)
$2.9m +207.31%
($1.7m) -156.61%
$2.5m +247.86%
($7.6m) -411.63%
($139.8m) -1731.11%
($66.4m) +52.49%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($8.0m) ($2.5m)
Net Income (Loss) Attributable to Noncontrolling Interest ($1.2m) $0
Depreciation, Depletion and Amortization $368k $339k $338k $718k $2.0m $4.7m $6.8m $7.1m $5.2m $2.3m $3.4m
Depreciation $368k $339k $338k $718k $1.4m $2.9m $3.3m $3.6m $700k $800k $1.7m
Amortization of Debt Issuance Costs $87k $121k $18k $13k $0 $0
Amortization of Intangible Assets $1.1m $3.0m $8.2m $9.7m $5.2m $2.7m $263k
Deferred Income Tax Expense (Benefit) ($1.5m) ($3.3m) ($20.1m) ($5.2m) ($62k) ($64k) $65k ($42.4m)
Share-based Payment Arrangement, Noncash Expense $777k $1.3m $1.5m $3.0m $6.0m $14.0m $25.3m $31.7m $30.9m $23.0m $21.6m
Share-based Payment Arrangement, Expense $777k $1.3m $1.5m $3.0m $6.0m $14.0m $25.3m $31.7m $16.5m $21.3m $21.6m
Goodwill, Impairment Loss $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $110.4m $5.8m $0 $0
Income (Loss) from Equity Method Investments ($1.0m) ($672k) ($739k) $0
Nonoperating Income (Expense) ($3.2m) ($1.5m) ($396k) ($3.0m) $5.0m $6.2m $714k $4.6m ($4.3m) $4.5m
Other Nonoperating Income (Expense) $289k $704k $1.3m $497k $1.8m
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $264k ($172k) $2.0m $290k $1.8m $10.1m $10.8m ($15.4m) $2.9m ($264k) ($1.5m)
Increase (Decrease) in Inventories $291k $89k $1.7m $3.8m $629k ($114k) $6.6m $8.6m ($781k) $1.3m ($8.0m)
Inventory Write-down $5.7m
Increase (Decrease) in Accounts Payable $233k $21k ($11k) $768k ($171k) $2.0m $414k ($8.4m) $26k ($2.1m) ($795k)
Net Cash Provided by (Used in) Operating Activities ($4.3m)
$605k +113.98%
$2.3m +288.02%
$1.2m -48.34%
$6.6m +447.82%
($4.6m) -169.12%
($8.5m) -84.80%
($12.5m) -47.24%
$8.4m +167.46%
$20.1m +138.58%
$16.9m -16.10%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $144k $144k $500k $675k $2.0m $8.4m $10.4m $6.4m $3.2m $9.5m ($19.1m)
Gain (Loss) on Disposition of Property Plant Equipment ($1k) $0 $0 $0 ($482k) ($745k) ($633k) ($154k) ($11k) ($24.0m)
Gain (Loss) on Investments $1.3m $0 $697k $0 ($4.1m) $0 ($697k)
Payments to Acquire Investments $0 $6.0m ($87.1m)
Unrealized Gain (Loss) on Investments $451 $0 $0 $0 $0
Net Cash Provided by (Used in) Investing Activities $393k ($144k) ($6.5m) ($27.0m) ($24.7m) ($13.2m) ($58.1m) $17.8m $58.3m ($71.5m) ($8.2m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $284k $0 $0
Proceeds from Issuance of Common Stock $0 $100.1m $0 $0 $10.2m $0 $0 $0
Dividends Payable, Current $106k
Proceeds from (Payments for) Other Financing Activities ($159k) ($55k) ($124k) ($337k) $64k ($74k) $33k
Net Cash Provided by (Used in) Financing Activities $3.2m
$4.8m +51.45%
$28.1m +486.85%
$1.6m -94.33%
$102.1m +6295.86%
($2.8m) -102.72%
$16.3m +687.33%
$10.6m -35.09%
($6.8m) -164.04%
($10.9m) -61.05%
($16.5m) -51.44%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5.3m $24.0m ($24.2m) $84.0m ($20.6m) ($50.3m) $15.9m $59.9m ($62.3m) $24.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $90.5m $69.9m $19.5m $35.4m $24.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $508k $1.2m $1.5m $1.4m $323k $507k $202k $18k
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 $0 $452k $586k $1.9m $1.6m $762k
Income Taxes Paid, Net $64k
Additional Financial Items
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net $10.1m $0 $0 $0
Deconsolidation, Gain (Loss), Amount ($2.8m) $0
Foreign Currency Transaction Gain (Loss), Unrealized $0 $0 $50k ($56k) ($18k) $0
Gain (Loss) on Disposition of Business $15.9m $10.3m
General and Administrative Expense $4.6m $4.5m $6.0m $8.9m $14.6m $32.4m $47.7m $55.7m $40.5m $45.5m
Goodwill $33.6m $58.4m $224.7m $224.7m $224.7m $212.3m $208.6m $0
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($11.4m) ($12.1m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($8.8m) $7.5m
Income Tax Expense (Benefit) $0 $0 ($1.5m) ($3.3m) ($20.1m) ($5.0m) $169k ($38k) $49k
Investment Income, Interest $506k $58k
Operating Expenses $9.6m $7.8m $9.9m
Revenue from Contract with Customer, Including Assessed Tax $19.7m $27.4m $48.1m $119.2m $161.8m $143.3m $82.3m $96.2m
Stock or Unit Option Plan Expense $612k $612k